SPD602 (FBS0701, SSP-004184)
SPD602-201
Phase 2 small_molecule completed
Quick answer
SPD602 (FBS0701, SSP-004184) for Transfusional Iron Overload is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Transfusional Iron Overload
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed